Communicators

are winners!

More News

09.05.2023
BioNxt Successfully Completes Pilot Study for Contract Development Customer
24.04.2023
BioNxt Secures Contract to Develop and Manufacture ODF Product for International Pharmaceutical Company
17.04.2023
BioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing Capacity
07.03.2023
BioNxt Solutions Acquires Novel Precision Drug Coating and Delivery Technology
01.03.2023
BioNxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease
13.02.2023
BioNxt Reports Update on Commercialization of Rotigotine Patch for Treatment of Parkinson's Disease
12.12.2022
BioNxt Solutions Signs Term Sheet for Novel Precision Drug Coating Platform Technology
21.11.2022
BioNxt Solutions Reports on Frankfurt CPHI Conference
10.11.2022
XPhyto Announces Name Change to BioNxt Solutions Inc.
18.10.2022
XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson's Disease Treatment